Jenfer Biosciences

Ambala, India Founded: 2015 • Age: 11 yrs
Manufacturing and supplying pharmaceutical formulations, including tablets and injections, with a focus on Pharma Franchise in India.

About Jenfer Biosciences

Jenfer Biosciences is a Healthcare company based in Ambala (India) founded in 2015. Manufacturing and supplying pharmaceutical formulations, including tablets and injections, with a focus on Pharma Franchise in India. Its Indian entity Jenfer Biosciences Private Limited reported revenue of β‚Ή96.2 Lakh. Jenfer Biosciences offers products and services including Tablets and Injections. Its focus areas include Distribution, Pharma Franchise, Distribution Rights and Pharmaceuticals.

Company details

Jenfer Biosciences is engaged in the manufacturing and supplying of a wide range of pharmaceutical formulations, such as tablets, injections, and capsules, which are DCGI approved and produced under ISO 9001:2000 and GMP WHO norms. The company provides Pharma Franchise and PCD rights across India, emphasizing quality assurance and timely delivery to ensure customer satisfaction. Products are analyzed for quality before distribution, supporting health improvement and disease treatment. A commitment to excellence is maintained through diverse team efforts and ethical standards.

  • Headquarters Ambala, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website jenferbio.com
  • Legal Name Jenfer Biosciences Private Limited
  • Date of Incorporation 26 May, 2015
  • Jurisdiction Ambala Cantt, Haryana, India
Key Metrics
  • Annual Revenue
    ₹96.2 Lakh

    FY 2026 · -14% YoY

  • Net Profit
    ₹15,642

    FY 2026 · 0% margin

  • EBITDA
    ₹86,100

    FY 2026 · 1% margin

Products & Services of Jenfer Biosciences

Jenfer Biosciences offers a comprehensive portfolio of products and services, including Tablets and Injections.

Tablets
Pharmaceutical Formulations

Tablets are manufactured and supplied for various therapeutic uses, including analgesics and antibiotics

Injections
Pharmaceutical Products

Injections are produced and supplied as DCGI-approved formulations for medical treatments

Board of directors of Jenfer Biosciences Private Limited (Jenfer Biosciences)

Jenfer Biosciences Private Limited is the primary company behind Jenfer Biosciences. The board of Jenfer Biosciences Private Limited currently have 4 directors; the longest-serving is Jitendra Mohan Roy, appointed in 2015.

DirectorDesignationAppointedTenureEntity
Jitendra Mohan Roy
DIN 02745087
Director26 May 201511 yrs 5 moJenfer Biosciences Private Limited
Sunita
DIN 06956116
Director26 May 201511 yrs 5 moJenfer Biosciences Private Limited
Munish Aggarwal
DIN 07181798
Director26 May 201511 yrs 5 moJenfer Biosciences Private Limited
Varesh Khanna
DIN 05142658
Director26 May 201511 yrs 5 moJenfer Biosciences Private Limited

Financials of Jenfer Biosciences

Figures of Jenfer Biosciences Private Limited, the primary company behind Jenfer Biosciences, for FY 2026. Revenue was ₹96.2 Lakh (-14% year on year). Net profit was ₹15,642 (0% margin). EBITDA was ₹86,100 (1% margin). Revenue has grown at a compounded annual rate of -13% over three years and -7% over five years.

  • ₹96.2 LakhRevenue · FY 2026 · -14% YoY
  • ₹15,642Net profit · 0% margin
  • ₹86,100EBITDA · 1% margin
  • ₹1 LakhPaid-up capital
  • -13%Revenue CAGR, 3 years
  • -7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Jenfer Biosciences Private Limited are on its company page.

Premium access

Detailed financial statements for Jenfer Biosciences

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Jenfer Biosciences

Jenfer Biosciences was founded in 2015.

Jenfer Biosciences is headquartered in Ambala, India. It is registered at Ambala, Haryana, India.

The primary company behind Jenfer Biosciences, Jenfer Biosciences Private Limited, reported revenue of β‚Ή96.2 Lakh for FY 2026, down 14% year on year.

Jenfer Biosciences is engaged in the manufacturing and supplying of a wide range of pharmaceutical formulations, such as tablets, injections, and capsules, which are DCGI approved and produced under ISO 9001:2000 and GMP WHO norms. The company provides Pharma Franchise and PCD rights across India, emphasizing quality assurance and timely delivery to ensure customer satisfaction. Products are analyzed for quality before distribution, supporting health improvement and disease treatment. A commitment to excellence is maintained through diverse team efforts and ethical standards.

Jenfer Biosciences offers Tablets and Injections.

Jenfer Biosciences operates through Jenfer Biosciences Private Limited.

The legal entities of Jenfer Biosciences currently have 4 directors, including Jitendra Mohan Roy, Sunita, Munish Aggarwal and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available